EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Developing Machine Learning‐Based Prognostic Models for Nonmelanoma Skin Cancer Patients With Comorbid Diabetes: A Retrospective Cohort Study

Junjie Huang, Claire Chenwen Zhong, Zhaojun Li, Zehuan Yang, Yu Jiang, Jinqiu Yuan, Jonathan Poon, Qi Dou, Martin C. S. Wong

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72050 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Nonmelanoma skin cancer (NMSC) is one of the most common malignancies worldwide, with increasing incidence. Type 2 diabetes mellitus (T2DM) is a prevalent comorbidity that may adversely affect cancer prognosis through shared metabolic and inflammatory pathways. This study aims to identify risk factors influencing the survival of NMSC patients with T2DM, construct and evaluate the performance of different predictive models, and develop a comprehensive risk score to accurately predict the survival probability of these patients. Methods We collected data from the Hong Kong Hospital Authority Data Collaboration Laboratory, including 1325 NMSC patients with T2DM between 2000 and 2020. Cox proportional hazards (CoxPH), least absolute shrinkage and selection operator‐Cox model (LASSO‐Cox), random survival forest (RSF), and survival tree were employed to construct prediction models. SHapley Additive exPlanations (SHAP) analysis was conducted to identify key risk factors and attribute model outputs. A risk score system was developed using the AutoScore‐Survival package. Results We identified seven significant predictors for poorer overall survival among patients with T2DM, including higher age at cancer diagnosis, male sex, smoking, longer duration of T2DM, elevated creatinine and glycated hemoglobin (HbA1c), and lower fasting glucose. The RSF model showed the highest predictive performance among the evaluated machine learning models. The tuned AutoScore‐Survival risk score system demonstrated good predictive performance (concordance index (C‐index) = 0.712 in the test set), and was based on the following variables: age at cancer diagnosis, duration of T2DM, creatinine, insulin treatment, stroke, and HbA1c. The areas under the curve (AUCs) at 1, 3, and 5 years in the test set were 0.677, 0.697, and 0.729, respectively. Conclusion Older age at cancer diagnosis, male sex, longer diabetes duration, smoking, elevated creatinine and HbA1c, and lower fasting glucose were identified as adverse prognostic factors for NMSC patients with T2DM. The RSF model outperformed other algorithms in predictive accuracy. The proposed risk score offers a clinically interpretable and effective means of predicting survival among NMSC patients with T2DM.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →